Psychedelic Therapy's Efficacy Questioned Against Traditional Antidepressants

A recent study investigating treatments for depression has concluded that psychedelic-assisted therapy (PAT) was not more effective than open-label traditional antidepressants (TADs) in clinical trials. This finding challenges some of the optimistic views surrounding PAT.

The research indicated that blinding protocols influenced the effectiveness observed for TADs, but this effect was not present for PAT, suggesting that PAT trials are consistently open-label.

The study's conclusions highlight a critical methodological aspect: blinding integrity in clinical research is paramount. The noted influence of blinding protocols on TAD effectiveness, contrasted with its absence in PAT trials, suggests a fundamental difference in how these therapies are assessed.